APA (7th ed.) Citation

A, C., C, W., D, C., G, R., A, M., D, B., . . . Investigators, R. (2004). No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: Randomised, double-blind, placebo-controlled trial. Lancet, 363(9407), 429. https://doi.org/10.1016/s0140-6736(04)15489-5

Chicago Style (17th ed.) Citation

A, Carr, et al. "No Effect of Rosiglitazone for Treatment of HIV-1 Lipoatrophy: Randomised, Double-blind, Placebo-controlled Trial." Lancet 363, no. 9407 (2004): 429. https://doi.org/10.1016/s0140-6736(04)15489-5.

MLA (9th ed.) Citation

A, Carr, et al. "No Effect of Rosiglitazone for Treatment of HIV-1 Lipoatrophy: Randomised, Double-blind, Placebo-controlled Trial." Lancet, vol. 363, no. 9407, 2004, p. 429, https://doi.org/10.1016/s0140-6736(04)15489-5.